Company Filing History:

3 out of 13

Enzo Diagnostics, Inc.

patents

2 out of 7

Enzo Life Sciences, Inc. C/o Enzo Biochem, Inc.

Years Active: 1993-2012

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8097405 - Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs (2012-01-17),

2. 7220854 - Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides (2007-05-22),

3. 6992180 - Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides (2006-01-31),

4. 5384241 - Specific binding assay compound with inhibitive self-quenching (1995-01-24),

5. 5260433 - Saccharide specific binding system labeled nucleotides (1993-11-09),

6. 5241060 - Base moiety-labeled detectable nucleatide (1993-08-31),

Title: The Innovations of Stanley Kline

Introduction

Stanley Kline is a notable inventor based in Brooklyn, NY. He has made significant contributions to the field of nucleic acid detection and characterization. With a total of 6 patents to his name, Kline's work has advanced the methodologies used in genetic research and diagnostics.

Latest Patents

Kline's latest patents focus on nucleic acid sequencing processes that utilize non-radioactive detectable modified or labeled nucleotides or nucleotide analogs. One of his key inventions involves a process for determining the sequence of nucleic acids of interest by employing nucleotides that have been made detectable through non-radioactive modifications. These modifications can occur on various moieties, including sugar, phosphate, or base moieties. His inventions also extend to the use of these modified nucleotides in detecting the presence of nucleic acids and characterizing chromosomal sequences. Additionally, he has developed sugar moiety labeled nucleotides that serve as diagnostic tools and therapeutic agents.

Career Highlights

Throughout his career, Kline has worked with several prominent companies, including Enzo Diagnostics, Inc. and Enzo Life Sciences, Inc. C/o Enzo Biochem, Inc. His work in these organizations has allowed him to contribute to the development of innovative diagnostic tools and therapeutic solutions.

Collaborations

Kline has collaborated with notable professionals in his field, including Dean L Engelhardt and Elazar S Rabbani. These collaborations have further enriched his research and development efforts.

Conclusion

Stanley Kline's contributions to the field of nucleic acid detection and characterization have made a lasting impact on genetic research. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.